Metraipolis › archive › dc_f04db027458d

Dendritic Cell Therapy in Immuno-Oncology: A Potentially Key Component of Anti-Cancer Immunotherapies — Europe PMC PMID:41514632

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41514632
DOI
10.3390/cancers18010123
License (as archived)
solo-consultazione
Archived
2026-11-07T08:07:00.116Z
SHA-256 of the archived text
91fc27176fee14c7f78ec187835341973f9459a46b9542476fc3d8c6f86d5c87
Stable URL of this page
https://metraipolis.com/documento/dc_f04db027458d

How to cite

Dendritic Cell Therapy in Immuno-Oncology: A Potentially Key Component of Anti-Cancer Immunotherapies — Europe PMC PMID:41514632 — Europe PMC (en), https://europepmc.org/article/MED/41514632 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f04db027458d (Metraipolis archive dc_f04db027458d, sha256 91fc27176fee14c7f78ec187835341973f9459a46b9542476fc3d8c6f86d5c87)
BibTeX
@misc{dcf04db027458d,
  title = {Dendritic Cell Therapy in Immuno-Oncology: A Potentially Key Component of Anti-Cancer Immunotherapies — Europe PMC PMID:41514632},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41514632},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f04db027458d; sha256 91fc27176fee14c7f78ec187835341973f9459a46b9542476fc3d8c6f86d5c87},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41514632. Agents can read the archived copy with the MCP tool read_document.